Telehealth

AI primary care firm Counsel Health is expanding into chronic and lifestyle conditions, aiming to disrupt traditional healthcare with its messaging-based model.

Carenet Health acquires Response BPO, leveraging South Africa's talent and its own AI to tackle U.S. healthcare costs and enhance patient engagement.

Meet three social enterprises in Pakistan, South Africa, & India whose proven models for change just earned them the prestigious $2M Skoll Award.

A new bispecific antibody aims to treat the 50% of AxSpA patients who find no relief, as Fortitude Biomedicines enters a competitive autoimmune market.

Life Sciences Ontario's new board appointments signal a strategic shift, bringing in leaders from medtech, agri-tech, pharma, and nuclear isotopes.

AIRNA has dosed the first patient with AIR-001, an RNA-editing drug that could treat both the lung and liver damage of a devastating genetic disease.

As Florida cuts its AIDS drug program, a telehealth company steps in to offer free care, exposing a growing crisis in state-level healthcare access.

Amid a severe specialist shortage, a new digital platform is empowering Arizona's frontline doctors to provide faster mental health care for kids and new moms.

Three years in, Blue Shield's Virtual Blue plan shows impressive results in cutting costs, slashing wait times, and boosting patient satisfaction.

Dxcover's new AI platform uses infrared light to detect early-stage colorectal, pancreatic, and ovarian cancers from blood with unprecedented sensitivity.

OneLegacy launches a massive campaign to address SoCal's organ shortage, where 20,000 wait for a second chance at life. Here's how you can help.

For a second year, ABA Centers ranks among the Americas' fastest-growing firms, tackling the autism care crisis with a disruptive, no-waitlist model.

Healthee's AI platform is now part of the Workday Wellness Program, promising to demystify health plans and cut costs for millions of employees.

A Virginia pilot program offers free clinical-grade bloodwork with donations, aiming to reverse a 40% drop in young donors and empower the uninsured.

As Stryker preps its Q1 2026 report, all eyes are on whether the MedTech giant can sustain its momentum amid new products and industry-wide pressures.

A stark new benchmark study reveals poor survival in late-stage GvHD, just as MaaT Pharma’s microbiome therapy shows dramatically better outcomes.

A key U.S. patent extends protection for a promising CRPS-1 drug, paving the way for a potential first-in-class treatment for the debilitating condition.

Canadian innovator Stealth Health enters the U.S. with a dual-model telemedicine platform for longevity, targeting both patients and healthcare providers.

Two homegrown firms are building AI-powered hubs for at-home care, aiming to support Canada's strained system and aging population before it's too late.

After a transformative year with key FDA/EU approvals, Pulsenmore's financials get a one-time boost. Can it now conquer the remote prenatal care market?